Masterflex SE Reports Record 2025 Performance
Masterflex SE, listed on Xetra, disclosed its 2025 annual report on 31 March 2026. The company announced a 4.6 % increase in group revenue, reaching EUR 102.6 million compared with EUR 98.1 million in 2024.
Operating earnings before interest, taxes, depreciation and amortisation (EBITDA) rose by 7.4 %, achieving a new record of EUR 19.5 million. The improvement reflects continued growth across the company’s high‑tech specialty plastics and polyurethane product lines.
Key Highlights
- Revenue Growth: 4.6 % year‑on‑year, driven by expansion in medical devices and industrial hose systems.
- EBITDA: 7.4 % increase, underscoring efficient cost management and strong pricing power.
- Strategic Momentum: The report emphasizes new growth projects that are expected to sustain the upward trajectory.
Market Context
On 30 March 2026, the share price settled at EUR 13.45, down 2.18 % from the previous session. The 52‑week high of EUR 14.95 (17 August 2025) and a low of EUR 8.36 (6 April 2025) illustrate a volatile but generally bullish trend for the stock.
Resilience in Uncertain Conditions
Masterflex’s management highlighted its ability to maintain profitability amid a challenging economic climate. Diversification across multiple sectors—particularly the more stable medical technology and food industries—helps buffer against downturns in cyclically sensitive markets.
Financial Metrics
- Market Capitalisation: EUR 131.29 million
- Price‑to‑Earnings Ratio: 14.86
The company’s performance, as reported, reaffirms its position as a leading producer of high‑tech specialty plastics and polyurethane solutions for industrial and medical applications.
